WuXi Advanced Therapies

1 month ago | outsourcedpharma.com | Louis Garguilo |Brandon Haigh |WuXi Advanced Therapies |Raul P. Lima

Join Outsourced Pharma Live for an in-depth examination on how the BIOSECURE Act is impacting risk management, compliance, and the future of global outsourcing in drug development and manufacturing. Our supply-chain experts will provide actionable insights to ensure your outsourcing strategies align with the greater legal, regulatory and geopolitical environment.

Oct 28, 2024 | cellandgene.com | Tyler Menichiello |Joonman Hong |GC Cell |WuXi Advanced Therapies

It's no secret that on-going research aims to improve the efficacy and specificity of non-viral approaches for genetic engineering. But the field is rapidly evolving with research aimed at improving transfection efficiency, targeting, and safety profiles of non-viral delivery systems. Join Cell & Gene Live to discuss the most notable approaches and recent breakthroughs as well as promising non-viral vectors used in clinical trials. Attendance is free thanks to the support of MaxCyte.